Bracco company information, Employees & Contact Information

Bracco Imaging and Subtle Medical Announce CE Mark of AiMIFY™ Software for Enhanced MRI in Europe PR Newswire

Bracco Imaging Earns EcoVadis Platinum Medal for Global Sustainability Leadership PR Newswire

Bracco and Aenitis Join Forces to Develop “Acoustic Beads” GlobeNewswire

Bracco Diagnostics Inc. AuntMinnie

Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency PR Newswire

Bracco Diagnostics Inc. Launches Update to HeartSee™ With New Features and Expanded Access to Cutting-edge Technology for Coronary Artery Disease Diagnosis PR Newswire

Bracco Diagnostics Inc. Introduces Innovative "Mini" Packaging for VARIBAR® (barium sulfate), Catering to Diverse Customer Needs PR Newswire

Bracco Diagnostics Inc. Branded Max 3™, a Rapid Exchange and Syringeless Injector, received FDA 510(k) clearance adding evolving innovation in Magnetic Resonance Imaging (MRI) and its product portfolio PR Newswire

Bracco Diagnostics Inc. Obtains Hallmark Achievement of One Million Injections with its MRI agent VUEWAY® (gadopiclenol) solution for injection PR Newswire

BRACCO IMAGING S.p.A. ANNOUNCES A NEW AGREEMENT WITH SONOTHERA™ TO EXPLORE THE EMERGING FIELD OF ULTRASOUND-GUIDED NONVIRAL GENE THERAPY PR Newswire

Bracco Diagnostics Inc. Announces Update on Product Portfolio PR Newswire

Bracco Elevates Next Generation of Radiologists, Announces Recipients of the 2022 "Leaders on the Horizon" Residency Program PR Newswire

Bracco Diagnostics Inc. Announces New Partnership to Increase Access to Cardiac PET Imaging PR Newswire

Preeminent Hospitals and Medical Practices Nationwide Lead in Patient Care with First Use of Bracco's VUEWAY™ (gadopiclenol) solution for injection for MRI PR Newswire

Bracco Diagnostics Inc. Introduces CitraClear™, a Refreshing Pre-Procedure Hydration Solution, to the Healthcare Community PR Newswire

Bracco Diagnostics Inc. Introduces New CardioGen-82® (Rubidium Rb 82 Generator) Infusion System PR Newswire

Bracco Launches Global "BRACCO CARES" Initiative to Support Healthcare Professionals Through Trying Times PR Newswire

Bracco Diagnostics Inc.'s LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use, receives U.S. Food and Drug Administration approval for use in echocardiography to opacify the left ventric PR Newswire

Bracco Announces U.S. FDA Approval of 20-Vial Configuration of LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use PR Newswire

FDA Grants Import Discretion of Bracco's Iodinated Contrast Medium Iomeron® (iomeprol injection) to Address Supply Shortages PR Newswire

Bracco Diagnostics Inc. Unveils Contrast Media and Device Offerings That Can Help Build Value and Drive Revenue in Clinical Practice at the 2019 Radiological Society of North America (RSNA) Annual Meeting PR Newswire

Bracco and the Society for Advanced Body Imaging (SABI) Announce Partnership in Launch of the New SABI Bracco Mentorship Program PR Newswire

Bracco Diagnostics Inc. Receives First U.S. FDA Approval For Barium-Based Product Used For Contrast Radiography PR Newswire

Bracco Diagnostics Inc. Receives Second U.S. FDA Approval for Barium-Based Products, The First in Computed Tomography PR Newswire

Bracco Diagnostics Inc. receives U.S. Food and Drug Administration (FDA) approval for use of MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL in magnetic resonance imaging (MRI) of the central nervous system (CNS) in pediatric patients young PR Newswire

Bracco Diagnostics Inc. Receives Innovative Technology Designation from Vizient for LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension for Contrast Echocardiography PR Newswire

Bracco Diagnostics Inc.'s LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use, receives U.S. Food and Drug Administration approval for use in ultrasonography of the urinary tract in pedia PR Newswire

FDA Approves Bracco Diagnostics Inc.'s ProHance® (Gadoteridol) Injection, 279.3 mg/mL, for Pediatric Patients Younger than Two Years PR Newswire

Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol PR Newswire

Voluntary dismissal of Norris case PR Newswire

First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use PR Newswire

Bracco Imaging Receives FDA Fast Track Designation for BR55, Ultrasound Molecular Imaging Agent for the Detection of Active Bowel Inflammation in Crohn's Disease PR Newswire

American College of Radiology Classifies VUEWAY® as a Group II Agent Relative to NSF PR Newswire

Bracco Imaging S.p.A. and BURL Concepts, Inc. Form Strategic Partnership to Revolutionize Stroke Care PR Newswire

Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® THIN LIQUID (barium sulfate) for oral suspension PR Newswire

Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound PR Newswire

Digadoglucitol: A New High Relaxivity MRI Contrast Agent Based on the Dimerization of [Gd(HP-DO3A)] and Activated Intramolecular Catalysis of the Prototropic Exchange ACS Publications

Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package b PR Newswire

The Centers For Medicare & Medicaid Services (CMS) Approved Coverage And Coding For Abdominal Ultrasound With Contrast Under The Hospital Outpatient Prospective Payment System (HOPPS) Effective October 1, 2016 PR Newswire

MultiHance launched in Russia healthcare-in-europe.com

-Functionalized Derivatives and their Supramolecular Adducts with Human Serum Albumin ACS Publications

Bracco Imaging acquires SurgVision expanding into the innovative field of fluorescence imaging-guided surgery PR Newswire

Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® PUDDING (barium sulfate) oral paste for Fluoroscopy PR Newswire

Importance of Myocardial Perfusion Positron Emission Tomography Recognized in New Joint Position Statement by the American Society of Nuclear Cardiology and the Society of Nuclear Medicine and Molecular Imaging PR Newswire

Bracco Diagnostics Inc. announces the launch of the PROTOCO2L TOUCH® Colon Insufflator for use in CT Colonography procedures PR Newswire

Bracco Showcases Immersive Digital Experience at RSNA20 Imaging Technology News

The United States Pharmacopeia (USP) Defines the Imaging Bulk Package (IBP) as the Only Suitable Container of Contrast Material for Multi-Dose, Multi-Patient Use Directly in Radiology Rooms PR Newswire

Bracco Diagnostics Inc. Receives U.S. FDA Approval for TAGITOL™ V (Barium Sulfate) Oral Suspension PR Newswire

TRASUTA: The Effect of the Structural Rigidity of a Mesocyclic AAZTA-like Chelating Agent on the Thermodynamic, Kinetic, and Structural Properties of Some Divalent Metal and Ga3+ Complexes ACS Publications

Bracco's CT Exprès™ 3D Contrast Media Delivery System is the First and Only Syringe-Less Computed Tomography (CT) Power Injector Available in the U.S. PR Newswire

Voluntary Dismissal of Chuck Norris Gadolinium Case Involving Bracco Imaging Technology News

Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension Imaging Technology News

Bracco and the European Society of Radiology build on long-standing partnership at ECR 2025 through new campaign to advance innovative and sustainable approaches in radiology Adnkronos

The European Commission Grants Marketing Authorization to Bracco Imaging for Vueway (gadopiclenol) Contrast Agent in the European Union Imaging Technology News

Bracco Diagnostics Highlights Contrast Media Milestones at RSNA 2016 Imaging Technology News

Lorraine Bracco Gets Choked Up Remembering Late Costars James Gandolfini, Tony Sirico and Ray Liotta People.com

Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® NECTAR (barium sulfate) Oral Suspension PR Newswire

Underlining the Importance of Peripheral Protic Functional Groups to Enhance the Proton Exchange of Gd-Based MRI Contrast Agents ACS Publications

Echocardiography Contrast Agent Approved for Medicare Reimbursement Diagnostic and Interventional Cardiology

Novel GBCAs Elucirem, Vueway Now Available for Use in Contrast Enhanced MRI Medical Professionals Reference

Characterization of the Fe(III)-Tiron System in Solution through an Integrated Approach Combining NMR Relaxometric, Thermodynamic, Kinetic, and Computational Data ACS Publications

Boosting Bismuth(III) Complexation for Targeted α-Therapy (TAT) Applications with the Mesocyclic Chelating Agent AAZTA Wiley Online Library

Bracco Launches CT Exprès 3-D Contrast Media Delivery System at RSNA 2016 Imaging Technology News

REALITYRx Communication: 2023 PharmaLive

Lorraine Bracco TV Insider

CHOP Radiologists Receive $300,000 Grant for Contrast Ultrasound Research and Education Imaging Technology News

Medtronic Enters the FFR and IVUS Technology Field With ACIST Co-Promotion Agreement Angioplasty.Org

ACIST Launches HDi High-Definition IVUS PR Newswire

FDA Expands Labeling of MultiHance for Magnetic Resonance Angiography Imaging Technology News

‘I Was Heartbroken’: The Sopranos’ Lorraine Bracco On Disliking How Tony And Melfi’s Story Ended And What She Thinks Happened To Them After The Series Finale Cinemablend

Samsung Medison and Bracco Imaging Forge Path with New Diagnostic Ultrasound Technology Agreement at ECR 2024 Macau Business

ACIST Launches The RXi™ Rapid Exchange FFR System PR Newswire

FFR-SEARCH Shows Clear Trend Towards Major Adverse Cardiac Events with Lower FFR PR Newswire

New Radiotracers Hold Promise for Better Nuclear Imaging Diagnostic and Interventional Cardiology